(Q36777844)

16 August 2017

1 reference

title

Interactions and management issues in HSV and HIV coinfection (English)

1 reference

16 August 2017

Meghna Ramaswamy

1

1 reference

16 August 2017

Anna Maria Geretti

series ordinal

2

1 reference

16 August 2017

publication date

1 April 2007

1 reference

Expert Review of Anti-infective Therapy

16 August 2017

published in

1 reference

16 August 2017

volume

5

1 reference

16 August 2017

issue

2

1 reference

16 August 2017

page(s)

231-243

1 reference

Severe Acquired Immunodeficiency in Male Homosexuals, Manifested by Chronic Perianal Ulcerative Herpes Simplex Lesions

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Interferon gamma production by herpes simplex virus antigen-specific T cell clones from patients with recurrent herpes labialis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Direct recovery of herpes simplex virus (HSV)-specific T lymphocyte clones from recurrent genital HSV-2 lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Gamma interferon can block herpes simplex virus type 1 reactivation from latency, even in the presence of late gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Severe genital herpes infections in HIV-infected individuals with impaired herpes simplex virus-specific CD8+ cytotoxic T lymphocyte responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Frequent reactivation of herpes simplex virus among HIV-1-infected patients treated with highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Association between human immunodeficiency virus and herpes simplex virus type 2 seropositivity among male factory workers in Zimbabwe

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Herpes simplex virus type 2: epidemiology and management options in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Herpes simplex virus type 2 in the United States, 1976 to 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

The seroepidemiology of herpes simplex virus type 1 and 2 in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Seroprevalence of herpes simplex virus types 1 and 2 in HIV-infected and uninfected homosexual men in a primary care setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

HIV infection and sexually transmitted infections among men who have sex with men in Senegal

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Prevalence of antibodies to human herpesviruses and hepatitis B virus in patients at different stages of human immunodeficiency virus (HIV) infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Prevalence and correlates of herpes simplex infections. The population-based AIDS in Multiethnic Neighborhoods Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

The epidemiology of HSV-2 infection and its association with HIV infection in four urban African populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

HIV-1 prevalence and herpes simplex virus 2, hepatitis C virus, and hepatitis B virus infections among male workers at a sugar estate in Malawi

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Prevalence of herpes simplex virus type 2 antibody in Cameroon

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Epidemiology of HIV infection in urban Burkina Faso

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Herpes simplex virus type 2 (HSV-2) seroprevalence at the time of HIV-1 diagnosis and seroincidence after HIV-1 diagnosis in an ethnically diverse cohort of HIV-1-infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

New estimates of herpes simplex virus type 2 seroprevalence in England: 'high' but stable seroprevalence over the last decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Seroprevalence of HSV-1 and HSV-2 in Barbados

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

HIV-1 DNA shedding in genital ulcers and its associated risk factors in Pune, India.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Genital shedding of herpes simplex virus-2 DNA and HIV-1 RNA and proviral DNA in HIV-1- and herpes simplex virus-2-coinfected African women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

The impact of active herpes simplex virus infection on human immunodeficiency virus load

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Determinants of HIV-1 load in subjects with early and later HIV infections, in a general-population cohort of Rakai, Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Activation of human immunodeficiency virus by herpes simplex virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Activation of human immunodeficiency virus by herpesvirus infection: identification of a region within the long terminal repeat that responds to a trans-acting factor encoded by herpes simplex virus 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Prior herpes simplex virus type 2 infection as a risk factor for HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Genital herpes simplex virus infection and perinatal transmission of human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Chronic herpes simplex virus type-2 infection and HIV viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Recent herpes simplex virus type 2 infection and the risk of human immunodeficiency virus type 1 acquisition in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Herpes simplex virus type 2 infection as a risk factor for human immunodeficiency virus acquisition in men who have sex with men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

High risk of human immunodeficiency virus in men who have sex with men with herpes simplex virus type 2 in the EXPLORE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Herpes simplex virus infection in women in the WIHS: epidemiology and effect of antiretroviral therapy on clinical manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

An indolent penile herpetic ulcer in a patient with previously undiagnosed human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Prevalence and risk factors of HSV-1 and HSV-2 antibodies in European HIV infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

A prospective study of genital herpes simplex virus type 2 infection in human immunodeficiency virus type 1 (HIV-1)-seropositive women: correlations with CD4 cell count and plasma HIV-1 RNA level

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

National survey of diagnostic services for genital herpes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Diagnosis of genital herpes by real time PCR in routine clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

The epidemiology of genital infection with herpes simplex virus types 1 and 2 in genitourinary medicine attendees in inner London.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Diagnosing herpesvirus infections by real-time amplification and rapid culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Diagnosing genital ulcer disease in a clinic for sexually transmitted diseases in Amsterdam, The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Polymerase chain reaction for diagnosis of genital herpes in a genitourinary medicine clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Identification of herpes simplex virus genital infection: comparison of a multiplex PCR assay and traditional viral isolation techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

A comparison of virus isolation, indirect immunofluorescence and nested multiplex polymerase chain reaction for the diagnosis of primary and recurrent herpes simplex type 1 and type 2 infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Detection of herpes simplex virus in genital specimens by type-specific polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Comparison of virus culture and the polymerase chain reaction for diagnosis of mucocutaneous herpes simplex virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Performance of a commercial, type-specific enzyme-linked immunosorbent assay for detection of herpes simplex virus type 2-specific antibodies in Ugandans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in African sera by using recombinant gG2, Western blotting, and gG2 inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Genital herpes. Type-specific antibodies for diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Interferon-gamma responses to Candida recover slowly or remain low in immunodeficient HIV patients responding to ART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Reconstitution of herpes simplex virus-specific T cell immunity in HIV-infected patients receiving highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Management of herpes simplex virus type 2 infection in HIV type 1-infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Recommendations for the selective use of herpes simplex virus type 2 serological tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Impact of suppressive herpes therapy on genital HIV-1 RNA among women taking antiretroviral therapy: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Acyclovir-resistant genital herpes among persons attending sexually transmitted disease and human immunodeficiency virus clinics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Development of herpes simplex virus disease in patients who are receiving cidofovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Treatment of acyclovir-resistant herpetic ulceration with topical foscarnet and antiviral sensitivity analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Phase II double-blind, placebo-controlled study of the safety and efficacy of cidofovir topical gel for the treatment of patients with human papillomavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Indirect ELISA for the detection of HSV-2 specific IgG and IgM antibodies with glycoprotein G (gG-2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

Regression of AIDS-related Kaposi's sarcoma following antiretroviral therapy with protease inhibitors: biological correlates of clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.5.2.231

21 January 2018

Identifiers

DOI

10.1586/14787210.5.2.231

1 reference

16 August 2017

1 reference